Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
29.31
-0.49 (-1.64%)
At close: Jun 6, 2025, 4:00 PM
29.40
+0.09 (0.31%)
After-hours: Jun 6, 2025, 5:32 PM EDT
Surmodics Market Cap
Surmodics has a market cap or net worth of $420.40 million as of June 6, 2025. Its market cap has decreased by -15.50% in one year.
Market Cap
420.40M
Enterprise Value
422.06M
1-Year Change
-15.50%
Ranking
Category
Stock Price
$29.31
Market Cap Chart
Since December 1, 1998, Surmodics's market cap has increased from $67.50M to $420.40M, an increase of 522.81%. That is a compound annual growth rate of 7.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 420.40M | -25.89% |
| Dec 31, 2024 | 567.30M | 10.24% |
| Dec 29, 2023 | 514.60M | 7.43% |
| Dec 30, 2022 | 479.00M | -28.45% |
| Dec 31, 2021 | 669.50M | 12.48% |
| Dec 31, 2020 | 595.20M | 6.04% |
| Dec 31, 2019 | 561.30M | -11.36% |
| Dec 31, 2018 | 633.20M | 72.63% |
| Dec 29, 2017 | 366.80M | 9.33% |
| Dec 30, 2016 | 335.50M | 27.86% |
| Dec 31, 2015 | 262.40M | -7.67% |
| Dec 31, 2014 | 284.20M | -15.16% |
| Dec 31, 2013 | 335.00M | 2.20% |
| Dec 31, 2012 | 327.80M | 27.55% |
| Dec 30, 2011 | 257.00M | 23.97% |
| Dec 31, 2010 | 207.30M | -47.64% |
| Dec 31, 2009 | 395.90M | -11.31% |
| Dec 31, 2008 | 446.40M | -54.99% |
| Dec 31, 2007 | 991.70M | 73.25% |
| Dec 29, 2006 | 572.40M | -16.56% |
| Dec 30, 2005 | 686.00M | 19.85% |
| Dec 31, 2004 | 572.40M | 38.03% |
| Dec 31, 2003 | 414.70M | -16.41% |
| Dec 31, 2002 | 496.10M | -18.92% |
| Dec 31, 2001 | 611.90M | 0.02% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |